Clinical Coagulation, Malmö
111 – 120 of 660
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Real-world prophylactic usage of recombinant factor VIII Fc in Sweden : A report from the Swedish national registry for bleeding disorders
- Contribution to journal › Letter
-
Mark
Comparison of single subject and population-based pharmacokinetics for optimizing prophylaxis with simoctocog alfa in patients with haemophilia A
- Contribution to journal › Article
-
Mark
A simplified decision rule to rule out deep vein thrombosis using clinical assessment and D-dimer
- Contribution to journal › Article
-
Mark
Impact of ABO blood group on bleeding complications after surgery for acute type A aortic dissection
- Contribution to journal › Article
-
Mark
Translating the success of prophylaxis in haemophilia to von Willebrand disease
- Contribution to journal › Scientific review
-
Mark
Treatment outcomes in persons with severe haemophilia B in the Nordic region : The B-NORD study
- Contribution to journal › Article
-
Mark
Validation of factor VIII activity for monitoring standard and extended half-life products and correlation to thrombin generation assays
- Contribution to journal › Article
-
Mark
Clinical characterization and identification of rare genetic variants in atypical hemolytic uremic syndrome : a Swedish retrospective observational study
- Contribution to journal › Article
-
Mark
Antibiotic Prescription Rates After eVisits Versus Office Visits in Primary Care : Observational Study
- Contribution to journal › Article
-
Mark
Optimising prophylaxis in haemophilia A : The ups and downs of treatment
- Contribution to journal › Scientific review
